As some states move to eschew social distancing recommendations by beginning plans to reopen businesses amid the coronavirus disease 2019 pandemic, a group of economists highlight in a recent study that the potential benefits of social distancing in saving lives far outweigh the projected damage to the economy.
As some states move to eschew social distancing recommendations by beginning plans to reopen businesses amid the coronavirus disease 2019 (COVID-19) pandemic, a group of economists highlight in a recent study that the potential benefits of social distancing in saving lives far outweigh the projected damage to the economy.
In the vast majority of states, the COVID-19 pandemic has led to unprecedented “stay-at-home” orders and the forced closure of all nonessential businesses. The growing unrest among some Americans seeking to expedite the economic shutdown is not unwarranted, as a recent forecast by Goldman Sachs predicts that social distancing measures will cause the nation’s gross domestic product to shrink by more than 6% this year, even with extensive government stimulus efforts. Moreover, the financial impact on businesses has been noted, with a study from Integrated Benefits Institute (IBI) indicating that employee benefits for absent workers could cost employers more than $23 billion in total.
However, as indicated in the IBI study, the ultimate financial burden depends on the eventual severity of the virus. In other words, if more people become infected and are then unable to work in any capacity, this could have dire financial repercussions for employers and the economy. Economists from the Department of Economics in the University of Wyoming (UW) College of Business sought to examine the risks and benefits of social distancing to the US economy, taking into account the potential impact of COVID-19 on the US healthcare system.
Published in the Journal of Benefit Cost Analysis,1 researchers estimated that the current social distancing measures across the country will reduce the average contact rate among individuals by 38%, which would then reduce the peak of the infection curve by more than half. Using epidemiological and economic forecasting to perform a rapid benefit-cost analysis, study authors indicated net benefits of about $5.2 trillion based on these social distancing measures.
“Social distancing saves lives but comes at large costs to society due to reduced economic activity. Still, based on our benchmark assumptions, the economic benefits of lives saved substantially outweigh the value of the projected losses to the US economy,” said lead study author Linda Thunstrom, PhD, assistant professor in the Department of Economics in the UW College of Business.
Noting a study limitation, economists said that their analysis does not consider the impact of a second wave of COVID-19 infections, as they assume that current social distancing policies will lead to the implementation of cost-effective COVID-19 treatments or vaccines.
So when will it be time to ease social distancing?
This is the current dilemma many state governments are facing when deciding how to approach the next 2 months of the pandemic. States such as Georgia have already announced that residents will be able to return to gyms, barbers, and massage parlors as early as Friday, in contrast to Virginia, where Governor Ralph Northam’s stay-home order for residents lasts until June 10, the longest duration across the United States.
Initial research touted by the Trump administration points to the pandemic potentially subsiding this summer, but in a study published in Science,2 researchers at Harvard T.H. Chan School of Public Health signal that the United States may have to endure social distancing measures until 2022 barring a vaccine, better therapeutics, or an increase in critical care capacity. Utilizing estimates of seasonality, immunity, and cross-immunity for 2 betacoronaviruses (OC43 and HKU1) from US time series data, researchers projected that future outbreaks of COVID-19 will occur in the winter after this initial, most-severe wave.
The study authors note that while this may seem unreasonable for the economy, their goal is to not endorse social distancing, but to “identify likely trajectories of the epidemic under alternative approaches, identify complementary interventions such as expanding ICU capacity and identifying treatments to reduce ICU demand, and to spur innovative ideas to expand the list of options to bring the pandemic under long-term control.”
As Americans indicated in a poll to be more concerned that the United States would lift restrictions related to COVID-19 too soon rather than concerned about the economic impact of the pandemic, social distancing measures may be best suited to remain until proper precautions, such as serological testing, can be implemented.
“Our analysis suggests that the aggressive social distancing policies currently promoted in the U.S. probably are justified, given that no good contingency plans were in place for an epidemic of this magnitude,” said thestudy authors from the UW College of Business. “But the costs and consequences will be painful. To avoid these in the future, there are likely large social benefits to ensuring that we are better prepared for the next pandemic.”
References
1. Thunstrom L, Newbold S, Finnoff D, et al. The benefits and costs of using social distancing to flatten the curve for COVID-19 [published online March 27, 2020]. J Benefit Cost Anal. doi: 10.2139/ssrn.3561934.
2. Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period [published online April 14, 2020]. Science. doi: 10.1126/science.abb5793.
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
October 31st 2024As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
August 31st 2021On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Listen
Prescription Rebate Guarantees: Employer Insights
July 19th 2024This study examined employers’ understanding of rebate guarantees, dependency upon rebate dollars, and the role that pharmaceutical rebates or employer benefits consultants play in their pharmacy benefits manager selection.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
October 31st 2024As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
August 31st 2021On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Listen
Prescription Rebate Guarantees: Employer Insights
July 19th 2024This study examined employers’ understanding of rebate guarantees, dependency upon rebate dollars, and the role that pharmaceutical rebates or employer benefits consultants play in their pharmacy benefits manager selection.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
2 Commerce Drive
Cranbury, NJ 08512